January 11, 2018 / 5:48 PM / in a month

BRIEF-FDA Revises Labeling For Prescription Opioid Cough Medicines In Children Below 18 Years

Jan 11 (Reuters) - U.S. Food and Drug Administration:

* U.S. FDA SAYS IS REQUIRING SAFETY LABELING CHANGES TO LIMIT USE OF PRESCRIPTION OPIOID COUGH MEDICINES WITH CODEINE/HYDROCODONE IN CHILDREN BELOW 18 YRS

* ‍U.S. FDA SAYS LABELING FOR PRESCRIPTION OPIOID COUGH MEDICINES WITH CODEINE/HYDROCODONE BEING UPDATED FOR ADULT USE, INCLUDING EXPANDED BOXED WARNING‍​​ Source text: (bit.ly/2Ex6nUe)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below